LP411834-7
MYCN gene amplification
Active
Description
MYCN gene amplification studies evaluate the number of copies of the MYCN gene present in a single cell to aid in determining the prognosis of neurobastoma (NBL) patients. The MYCN gene encodes for a protein involved in the formation of tissues and organs during fetal development. It can also be an oncogene that regulates gene transcription. Amplification is determined based on the MYCN gene copy number and MYCN to centromere ratio (CEP2). An MYCN/CEP2 ratio of >= 2.0 is an indication of aggressive tumor progression of neuroblastoma. PMID: 9779703 Source: Regenstrief LOINC
Basic Part Properties
- Part Display Name
- MYCN gene amplification
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2019-10-03
- Construct for LOINC Short Name
- MYCN amplification
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP411834-7
Language Variants Get Info
| Tag | Language | Translation |
|---|---|---|
| zh-CN | Chinese (China) | MYCN 基因扩增 Synonyms: MYCN 原癌基因, BHLH 转录因子; |
| nl-NL | Dutch (Netherlands) | MYCN-genamplicatie |
| it-IT | Italian (Italy) | MYCN, amplificazione gene Synonyms: Amplificazione del gene MYCN |
| es-ES | Spanish (Spain) | Amplificación del gen MYCN |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright